In addition, silencing CSF1R increased apoptosis in BPH-1 cells (Fig. 3h), and pharmacologic blockade with pexidartinib similarly reduced proliferation and increased apoptosis (Supplementary Fig. S3b–3c). This evidence concerns the gene CSF1R and benign prostatic hyperplasia.